The US government’s call for deep nicotine reduction in cigarettes could save millions of lives – an expert who studies tobacco addiction explains
The proposed standard would lower the nicotine content in cigarettes and cigars by 95% – a public health proposal that could prevent millions from becoming smokers in the first place.
Aug. 4, 2022 • ~9 min
At last, COVID-19 shots for little kids – 5 essential reads
The FDA’s authorization of COVID-19 shots for children ages 6 months to 4 years will bring relief for millions of parents. Pending CDC endorsement, shots for this group will be available within days.
June 17, 2022 • ~9 min
Dangerous counterfeit drugs are putting millions of US consumers at risk, according to a new study
Prescription opiods, stimulants such as those used to treat ADHD and the ingredients found in sexual dysfunction drugs like Viagra are some of the drugs that are being marketed to US consumers.
May 25, 2022 • ~6 min
The dietary supplement you're taking could be tainted with prescription medications and dangerous hidden ingredients, according to a new study
Products aimed at sexual dysfunction and weight loss were the most common dietary supplements that contained hidden – and potentially harmful – ingredients.
April 26, 2022 • ~6 min
Do you need a second booster shot? An epidemiologist scoured the latest research and has some answers
New data on the second booster suggests the older you are, the more you need it.
April 13, 2022 • ~9 min
In research studies and in real life, placebos have a powerful healing effect on the body and mind
Drug manufacturers often shun the use of placebos in clinical trials. But research suggests that placebos could play an important role in the treatment of depression, pain and other maladies.
Feb. 11, 2022 • ~11 min
The FDA's lax oversight of research in developing countries can do harm to vulnerable participants
Regulatory loopholes for research conducted off US soil allow for questionable trials and misleading data to slip under the FDA’s radar.
Nov. 12, 2021 • ~5 min
How Theranos' faulty blood tests got to market – and what that shows about gaps in FDA regulation
The FDA has chosen not to regulate lab-developed tests like the ones at the center of the Theranos trial.
Oct. 5, 2021 • ~9 min
/
2